Infectious Diseases Institute Trainee Association Day

The 4th Annual Infectious Diseases Institute Trainee Association (IDI-TA) Day is one-day event will be packed full of talks from fellow trainees (undergraduate, graduate, professional, post-doc, and research scientists) and will feature a keynote address presented by Dr. Mitchell Kronenberg, professor and president emeritus, La Jolla Institute for Immunology. Breakfast and lunch will be provided.

Research presentation opportunity

Master of Science and PhD students, post-docs and research associates are invited to submit abstracts when registering for IDI-TA Day. Selected speakers from each researcher category will be given awards.

Abstract format: Abstracts must be 300 words or less, and should be submitted via registration link for IDI-TA Day. Abstracts that exceed the 300 – word limit OR not following the format below, will be returned for modification. Please follow the instructions below: 

• Type the text in ARIAL font, 11 point
• The title should be capitalized and bold, followed by the author’s names (initials and last names only) and department aPiliation 
• Underline the presenting author’s name
• Abstract should be single-spaced
• Include “Keywords” at the end
• The 300 – word limit does NOT include title, authors, department information, and key words
• Please include your position, i.e. master's student, PhD student, post-doctoral, research associate

Keynote

Mitchell Kronenberg
Professor, President Emeritus
La Jolla Institute for Immunology

Mitchell Kronenberg is a distinguished immunologist and the Chief Scientific Officer at the La Jolla Institute for Immunology. He served as the President of the institute from 2003 to 2021 and has been a leading figure in immunology research for decades. His work focuses on innate-like T lymphocytes, including natural killer T (NKT) cells, mucosalassociated invariant T (MAIT) cells, and gamma-delta (γδ) T cells, as well as innate lymphoid cells (ILCs). Kronenberg’s research has significantly advanced our understanding of how these lymphocytes interact with their tissue environments and respond to pathogens. His studies have paved the way for innovative immunotherapies targeting cancer and inflammatory diseases, particularly inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis.

Kronenberg received his PhD from California Institute of Technology. In 1986, he joined the faculty at UCLA, where he was promoted to full professor in 1997. That same year, he transitioned to the La Jolla Institute for Immunology to lead the Division of Developmental Immunology. Kronenberg’s outstanding contributions to the field earned him numerous accolades, including the AAI Distinguished Service Award in 2016 and his election as a Distinguished Fellow of AAI in 2019. He has also been recognized as a Fellow of the American Association for the Advancement of Science, received the NIH NIAID Merit (R37) Award, and was named an Institute for Scientific Information (ISI) Highly Cited Scientist in 2007.

RSVP